Infliximab therapy for patients with ankylosing spondylitis: on-demand or continuous treatment?

Affiliations

¹ Rheumatology, Department, of Medicine I, Charité Medical School, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. joachim.sieper@charite.de

Comment

Joachim Sieper. Nat Clin Pract Rheumatol. 2008 Aug.

. 2008 Aug;4(8):398-9.

doi: 10.1038/ncprheum0846. Epub 2008 Jun 17.

¹ Rheumatology, Department, of Medicine I, Charité Medical School, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. joachim.sieper@charite.de

No abstract available

Comment on

Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.
Breban M, Ravaud P, Claudepierre P, Baron G, Henry YD, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X, Wendling D, Fautrel B, Fournié B, Combe B, Gaudin P, Jousse S, Mariette X, Baleydier A, Trape G, Dougados M; French Ankylosing Spondylitis Infliximab Network. Breban M, et al. Arthritis Rheum. 2008 Jan;58(1):88-97. doi: 10.1002/art.23167. Arthritis Rheum. 2008. PMID: 18163509 Clinical Trial.